Evidence map›Paper›PMID 40036086›Full record

ReviewJournal of the American Chemical Society2025

Advances in Organic Small Molecule-Based Fluorescent Probes for Precision Detection of Liver Diseases: A Perspective on Emerging Trends and Challenges.

Luling Wu, Zilu Li, Kun Wang, Robin R Groleau, Xiaodi Rong, Xueting Liu, Caiyun Liu, Simon E Lewis, Baocun Zhu, Tony D James

Abstract readReview
In one paragraph

Review in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luling WuDepartment of Chemistry, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0001-6574-5861
Zilu LiSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.
Kun WangSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.
Robin R GroleauDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0003-0213-5198
Xiaodi RongSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.
Xueting LiuSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.
Caiyun LiuSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.
Simon E LewisDepartment of Chemistry, University of Bath, Bath BA2 7AY, U.K.
Baocun ZhuSchool of Water Conservancy and Environment, University of Jinan, Jinan 250022, China.ORCID 0000-0002-6221-2071
Tony D JamesDepartment of Chemistry, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0002-4095-2191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver disease poses a significant challenge to global health, and its early diagnosis is crucial for improving treatment outcomes and patient prognosis. Since fluctuation of key biomarkers during the onset and progression of liver diseases can directly reflect liver health and normal/abnormal function, biomarker-based assays are vital tools for the early detection of liver disease. In this context, small molecule fluorescent probes have undeniably emerged as indispensable tools for diagnosis and analysis, with an ever-growing number of small molecule-based fluorescent probes being developed over recent years, with the sole aim of monitoring relevant biomarkers of liver disease. This perspective will focus on the development and application of probes developed primarily over the last 10 years for diagnosing a range liver disease-related processes. It will outline the foundational design strategies for developing promising probes, their optical response to key biomarkers, and how they have been demonstrated in proof-of-concept imaging applications. Current challenges and new developments in the field will be discussed, with the aim of providing insights and highlighting opportunities in the field.

Indexed as

Fluorescent DyesLiver DiseasesSmall Molecule LibrariesBiomarkersHumansOptical ImagingBiomarkersFluorescent DyesSmall Molecule Libraries

Identifiers

PMID40036086
PMCPMC11926879

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.